Latest News for: rubius

Edit

Vacant RI biotech space, once owned by Rubius Therapeutics, offered at 'deeply discounted price'

Business Journal 12 Mar 2024
The 135,000 square-foot facility on 19 acres in North Smithfield was purchased by Boston's The Davis Companies 13 months ago. It remains vacant ... .
Edit

FORNITE OG DE RUBIUS - ANIME POV - !merch

Bitchute 18 Nov 2023
Go to the source via the article link to view the video ....
Edit

Management Change - Form 8-K (Rubius Therapeutics Inc)

Public Technologies 06 Apr 2023
). UNITED STATES. SECURITIES AND EXCHANGE COMMISSION. WASHINGTON, D.C. 20549. FORM 8-K. CURRENT REPORT ... April 6, 2023. RUBIUS THERAPEUTICS, INC ... Not Applicable ... ¨ ... notified Rubius Therapeutics, Inc ... April 6, 2023 RUBIUS THERAPEUTICS, INC ... Rubius Therapeutics Inc.
Edit

Failure to Satisfy Listing Rule - Form 8-K (Rubius Therapeutics Inc)

Public Technologies 03 Mar 2023
). UNITED STATES. SECURITIES AND EXCHANGE COMMISSION. WASHINGTON, D.C. 20549. FORM 8-K. CURRENT REPORT ... RUBIUS THERAPEUTICS, INC ... ¨ ... As previously disclosed by Rubius Therapeutics, Inc ... Ms ... Mr ... Mr ... March 3, 2023 RUBIUS THERAPEUTICS, INC ... Rubius Therapeutics Inc.
Edit

Thinking about buying stock in Sorrento Therapeutics, Rubius Therapeutics, Ideanomics, SoundHound AI, or C3.ai?

PR Newswire 14 Feb 2023
NEW YORK, Feb. 14, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SRNE, RUBY, IDEX, SOUN, and AI ... SRNE. https.//www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=SRNE&prnumber=021420235  RUBY ... (Note ... .
Edit

Acquisition/Asset Disposal - Form 8-K (Rubius Therapeutics Inc)

Public Technologies 21 Dec 2022
). UNITED STATES. SECURITIES AND EXCHANGE COMMISSION. WASHINGTON, D.C. 20549. FORM 8-K. CURRENT REPORT ... RUBIUS THERAPEUTICS, INC ... N/A ... ¨ ... On December 21, 2022, Rubius Therapeutics, Inc ... Date. December 21, 2022 RUBIUS THERAPEUTICS, INC. By ... Rubius Therapeutics Inc.
Edit

Termination of Material Agreement - Form 8-K (Rubius Therapeutics Inc)

Public Technologies 14 Dec 2022
RUBIUS THERAPEUTICS, INC ... On December 12, 2022 (the "Effective Date"), Rubius Therapeutics, Inc ... 10.1 Agreement for Termination of Lease, dated December 12, 2022, by and between Rubius Therapeutics, Inc ... Rubius Therapeutics Inc.
Edit

Material Agreement - Form 8-K (Rubius Therapeutics Inc)

Public Technologies 12 Dec 2022
) ... 20549 ... RUBIUS THERAPEUTICS, INC ... N/A ... ¨ ... On December 6, 2022, Rubius Therapeutics, Inc ... 10.1* Purchase and Sale Agreement, dated December 6, 2022, by and between Rubius Therapeutics, Inc ... December12, 2022 RUBIUS THERAPEUTICS, INC ... Rubius Therapeutics Inc.
Edit

Former Rubius CEO jumps to another Flagship spinout

Business Journal 17 Nov 2022
Pablo Cagnoni, who was CEO of the soon-to-shutter Rubius Therapeutics Inc. until earlier this year, has joined another Flagship Pioneering-backed startup ... .
Edit

Rubius Therapeutics lays off most of its staff, explores sale

Business Journal 03 Nov 2022
Rubius Therapeutics is in the final days of its existence. The company is laying off 82% of its workforce and will begin looking at a sale or merger ... .
Edit

Accelaration/Increase of Financial Obligation - Form 8-K (Rubius Therapeutics Inc)

Public Technologies 13 Oct 2022
). UNITED STATES. SECURITIES AND EXCHANGE COMMISSION. WASHINGTON, D.C. 20549. FORM 8-K. CURRENT REPORT ... RUBIUS THERAPEUTICS, INC ... (617) 679-9600 ... On October 13, 2022, Rubius Therapeutics, Inc ... October 13, 2022 RUBIUS THERAPEUTICS, INC ... Rubius Therapeutics Inc.
Edit

Thinking about buying stock in Rubius Therapeutics, NextPlat, Seres Therapeutics, Cassava Sciences, or Alaunos Therapeutics?

PR Newswire 23 Sep 2022
NEW YORK, Sept. 23, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for RUBY, NXPL, MCRB, SAVA, and TCRT ... RUBY. https.//www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=RUBY&prnumber=092320222 NXPL ... (Note ... .
Edit

Rubius Therapeutics To Present At Guggenheim Nantucket Therapeutics Conference

MENA FN 19 Sep 2022
(MENAFN - GlobeNewsWire - Nasdaq) CAMBRIDGE, Mass., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq. RUBY), a biopharmaceutical company that is developing an entirely new class ... .

Most Viewed

×